Skip to Content

Temsirolimus

In the US, Temsirolimus (temsirolimus systemic) is a member of the drug class mTOR inhibitors and is used to treat Renal Cell Carcinoma.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01XE09

CAS registry number (Chemical Abstracts Service)

0162635-04-3

Chemical Formula

C56-H87-N-O16

Molecular Weight

1030

Therapeutic Category

Antineoplastic agent: Immunosuppressant

Chemical Names

(1R,2R,4S)-4-{(2R)-2-[(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-Dihydroxy-10,21-dimetoxy-6,8,12,14,20,26-hexametyl-1,5,11,28,29-pentaoxo-1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31,32,33,34,34a-tetracosahydro-3H-23,27-epox (WHO)

Rapamycin 42-(2,2-bis(hydroxymetyl)propionate)

Rapamycin, 42-(3-hydroxy-2-(hydroxymetyl)-2-metylpropanoate)

Foreign Names

  • Temserolimusum (Latin)
  • Temserolimus (German)
  • Temsirolimus (French)

Generic Names

  • Temsirolimus (OS: BAN, USAN, JAN)
  • CCl-779 (IS)
  • NSC-683864 (IS: WyethAyerst)
  • WAY-CCl 779 (IS)

Brand Names

  • Torisel
    Pfizer, Argentina; Pfizer, Austria; Pfizer, Australia; Pfizer, Belgium; Pfizer, Canada; Pfizer, Switzerland; Pfizer, Czech Republic; Pfizer, Germany; Pfizer, Denmark; Pfizer, Finland; Pfizer, France; Pfizer, United Kingdom; Pfizer, Greece; Pfizer, Hong Kong; Pfizer, Croatia (Hrvatska); Pfizer, Hungary; Pfizer, Ireland; Pfizer, Iceland; Pfizer, South Korea; Pfizer, Malaysia; Pfizer, Netherlands; Pfizer, Norway; Pfizer, Philippines; Pfizer, Poland; Pfizer, Portugal; Pfizer, Sweden; Pfizer, Singapore; Pfizer, Slovakia; Pfizer, Thailand; Pfizer, Turkey; Pfizer, Taiwan; Pfizer, South Africa; Pfizer Italia, Italy; Pfizer Japan, Japan; Pfizer Luxembourg, Bosnia & Herzegowina; Wyeth, Chile; Wyeth, Spain; Wyeth, Israel; Wyeth, Romania; Wyeth, Serbia; Wyeth Medica, Lithuania; Wyeth, Inc., United States

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide